Dementia in the News

CNN (November 9, 2013): Alzheimer's Risk Before Symptoms: Do You Want to Know?

Publication Date: 
Sat, 11/09/2013

Anne Kolesar thought she had packed well for her biking trip last month in Pennsylvania's "Grand Canyon," with clothes for cold weather and snacks. But after driving about a hundred miles, she looked through her rearview mirror and realized: Oops, no bike!

Kolesar, 61, laughs heartily as she tells this story. But hovering over the incident is her knowledge that she has an elevated genetic risk of Alzheimer's disease.

PR Newswire (November 7, 2013): Global CEO Initiative on Alzheimer's Disease Announces a Big Data Challenge to Find New Predictors of Cognitive Decline

Publication Date: 
Thu, 11/07/2013

The Global CEO Initiative (CEOi) on Alzheimer's Disease, Sage Bionetworks, and IBM's DREAM, today announced the Alzheimer's Disease Big Data (AD#1) Challenge at the Alzheimer's Disease Summit: The Path to 2025.

The Summit, hosted by CEOi and the New York Academy of Sciences, is convening key industry, academic, government, and patient stakeholders to build on the current National Institutes of Health (NIH) milestones designed to achieve a means of prevention and effective treatment of Alzheimer's by 2025.

CBS News (October 28, 2013): 11 New Gene Variants Linked to Alzheimer's Disease

Publication Date: 
Mon, 10/28/2013

In the largest genetic analysis of Alzheimer's ever completed, scientists have discovered 11 new genes that may be tied to the late-onset form of the dementia disease.

Scientists scanned the brains of 74,076 older volunteers with Alzheimer's and others who did not have the disease in 15 countries to come up with their findings. The study was published in Nature Genetics on Oct. 27.

Forbes (October 24, 2013): Medical Researchers Predict Progress in Battles Against Alzheimer's, Cancer

Publication Date: 
Thu, 10/24/2013

The frenzied pace of medical innovation was much in evidence at the Fourth Annual Galien Forum on Tuesday, at New York City’s Alexandria Center for Life Sciences. The world’s leading pharmaceutical researchers gathered to discuss the recent, significant advances in their understanding of human cellular biology, which hold out hope that doctors will be able to more effectively attack the scourges of Alzheimer’s, cancer, and diabetes in the not too distant future.

BBC News (October 10, 2013): Alzheimer's Breakthrough Hailed as 'Turning Point'

Publication Date: 
Thu, 10/10/2013

The discovery of the first chemical to prevent the death of brain tissue in a neurodegenerative disease has been hailed as the "turning point" in the fight against Alzheimer's disease.

More work is needed to develop a drug that could be taken by patients.

But scientists say a resulting medicine could treat Alzheimer's, Parkinson's, Huntington's and other diseases.

In tests on mice, the Medical Research Council showed all brain cell death from prion disease could be prevented.

Harvard Medical School News (October 10, 2013): Exercising the Mind

Publication Date: 
Thu, 10/10/2013

A protein increased by endurance exercise has been isolated and given to non-exercising mice, turning on genes that promote brain health and encourage the growth of new nerves involved in learning and memory, scientists from Harvard Medical School and Dana-Farber Cancer Institute have reported.

AlzForum (October 4, 2013); A Bird's-Eye View of Alzheimer's Research

Publication Date: 
Fri, 10/04/2013

As research on Alzheimer's disease becomes a growing societal priority worldwide, the National Institute on Aging and the Alzheimer's Association have launched the International Alzheimer's Disease Research Portfolio (IARDP). By organizing thousands of studies on AD into one central database, IADRP will help sponsors identify funded research to avoid duplication, coordinate funding efforts, and spot gaps in support. Researchers may fine it useful for the same reasons.

Boston Globe (September 30, 2013): Patient Starts Conversation on Alzheimer's

Publication Date: 
Mon, 09/30/2013

For 25 years, Charlie Collier traveled the country, seeking donations for Harvard University, where he gained a national reputation in the field of family philanthropy. Now, he is speaking out, as much as he is able, on a topic even closer to his heart:  Alzheimer's disease.

Five years ago, at age 60, Collier was diagnosed with early onset Alzheimer's. Though his speech and handwriting are somewhat impaired these days, Collier's intellect remains nearly as sharp as it was in 2001, when he published the groundbreaking book "Wealth in Families," now in its 11th printing.

Agencia EFE Salud (September 20, 2013): Los Avances Son Aire Fresco Para la Esperanza

Publication Date: 
Fri, 09/20/2013

El 21 de septiembre es el Día Mundial dedicado a la enfermedad de Alzheimer.

Una enfermedad que consume los sueños y las oportunidades de millones de pacientes y sus familias en todo el mundo, que golpea de forma especial en una de las etapas más vulnerables de la vida, cuando nuestra piel se empecina en arrugarse y más necesitamos la compañía de nuestros recuerdos de lo vivido.

Una enfermedad que, de momento, nos lleva ventaja en la partida y hoy figura entre las principales causas de mortalidad en nuestro país.

BBC News (September 18, 2013): Alzheimer's Brain Scan Detects Tau Protein

Publication Date: 
Wed, 09/18/2013

Pioneering brain imaging that can detect the build-up of destructive proteins linked to Alzheimer's has been developed by Japanese scientists.

It could lead to new ways of diagnosing the condition and of testing the effectivenewss of new drugs.

The technology, reported in the journal Neuron, can identify inside a living brain clumps of a protein called tau that is closely linked to the disease.

Alzheimer's Research UK said it was promising work.

Syndicate content